SCHEMBL27396972

SCHEMBL27396972

Clc1ccc(Oc2c[nH]c3ccccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 5/20 0.51
SLC22A6 Q4U2R8 2/20 0.46
STING1 Q86WV6 1/20 0.46
ALOX5 P09917 1/20 0.43
SENP7 Q9BQF6 1/20 0.42
LMNA P02545 2/20 0.41
KIF20A O95235 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTR2A P28223 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979309 0.91 SLC22A6 (0.53) SLC22A6NPSR1ATMTP53MAPT
SCHEMBL28007152 0.85 SLC22A6 (0.51) RHEBSLC22A6NPSR1ATMMAPT
SCHEMBL31744565 0.83 SLC22A6 (0.46) SLC22A6STING1LMNASLC6A4SLC6A2
SCHEMBL31744658 0.83 SLC22A6 (0.50) SLC22A6STING1SENP7LMNAHTR2A
SCHEMBL31744738 0.83 SMN1; SMN2 (0.54) SLC22A6SENP7NPSR1HTTTP53
SCHEMBL31744932 0.83 SLC22A6 (0.50) SLC22A6NPSR1ATMTP53
SCHEMBL3538344 0.81 SLC22A6 (0.58) SLC22A6HTR2ASLC6A4SLC6A2SLC6A3
SCHEMBL4920498 0.79 STING1 (0.49) SLC22A6STING1LMNAHTR2AHTT
SCHEMBL31744736 0.79 STING1 (0.49) SLC22A6STING1
SCHEMBL9047954 0.78 RHEB (0.72) RHEBHTR2ASLC6A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US claimed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
CN-101151530-A Technique for detecting microorganisms KIMBERLY CLARK CO (US) 2008-03-26 CN disclosed
CN-1081569-A agricultural composition for promoting plant photosynthesis SWALLOW ENTERPRISES CO (HK) 1994-02-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 RHEB 222/4885SLC22A6 2577/4885STING1 27/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 RHEB 222/4885SLC22A6 2577/4885STING1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.